NANOVIRICIDES, INC. 4
4 · NANOVIRICIDES, INC. · Filed Sep 24, 2015
Insider Transaction Report
Form 4
Seymour Eugene
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock Options
2015-09-18−142,856→ 0 totalExercise: $0.35From: 2005-06-30Exp: 2015-09-26→ Common Stock (142,856 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2015-09-22$0.35/sh+104,384$36,534→ 1,287,286 total - Tax Payment
Common Stock, par value $0.001 per share
2015-09-22$1.30/sh−38,472$50,014→ 1,248,814 total
Footnotes (2)
- [F1]Does not include 425,571 shares of Series A Convertible Preferred Stock (the "Series A") which vote at the rate of nine votes per share of Series A and is convertible into shares of Common Stock upon a change of control of the Company or upon the Common Stock achieving certain trading prices.
- [F2]Reflects 38,472 shares withheld by the Issuer at the market price of $1.30 per share, less an exercise price of $0.35 per share, to fund the cashless exercise of 142,856 options.